Evidence map›Paper›PMID 31368147›Full record

ArticleBritish journal of clinical pharmacology2019

Measuring the impact of pharmacovigilance activities, challenging but important.

Florence van Hunsel, Helga Gardarsdottir, Anthonius de Boer, Agnes Kant

Abstract readEditorial
In one paragraph

Article in British journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pharmacovigilance in China: Evolution and future challenges.British journal of clinical pharmacology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Effect of pharmaceutical regulatory policy on health impact.British journal of clinical pharmacology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Florence van HunselNetherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.ORCID 0000-0001-8965-3224
Helga GardarsdottirDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0001-5623-9684
Anthonius de BoerDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-9485-8037
Agnes KantNetherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDrug DevelopmentDrug-Related Side Effects and Adverse ReactionsHumansimpactpharmacovigilancerisk minimisation

Identifiers

PMID31368147
PMCPMC6783581

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.